Neuroleptic malignant syndrome: Possible induction by olanzapine in a case with relapsing catatonia

Int J Psychiatry Clin Pract. 2001;5(3):211-3. doi: 10.1080/136515001317021699.

Abstract

Neuroleptic malignant syndrome is a serious medical condition with a significant mortality risk. Although it is less common with the atypical than the typical agents, it is described in association with clozapine and olanzapine. This report documents a case of possible induction of NMS in a patient with relapsing catatonia.

Keywords: Olanzapine Catatonia Malignant Neuroleptic Syndrome Atypical Neuroleptic Schizophrenia.